204 related articles for article (PubMed ID: 14645966)
21. Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography.
Subramanian DR; Jenkins L; Edgar R; Quraishi N; Stockley RA; Parr DG
Am J Respir Crit Care Med; 2012 Dec; 186(11):1125-32. PubMed ID: 22837375
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
Balbi B; Ferrarotti I; Miravitlles M
Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
[No Abstract] [Full Text] [Related]
23. [Quantitative assessment of pulmonary emphysema with computerized tomography. Comparison of the visual score and high resolution computerized tomography, expiratory density mask with spiral computerized tomography and respiratory function tests].
Zompatori M; Battaglia M; Rimondi MR; Fasano L; Cavina M; Pacilli AM; Guerrieri A; Fabbri M; Vivacqua D; Biscarini M
Radiol Med; 1997 Apr; 93(4):374-81. PubMed ID: 9244913
[TBL] [Abstract][Full Text] [Related]
24. Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency.
Parr DG; Stoel BC; Stolk J; Stockley RA
Thorax; 2006 Jun; 61(6):485-90. PubMed ID: 16537666
[TBL] [Abstract][Full Text] [Related]
25. Short-term reproducibility of computed tomography-based lung density measurements in alpha-1 antitrypsin deficiency and smokers with emphysema.
Shaker SB; Dirksen A; Laursen LC; Maltbaek N; Christensen L; Sander U; Seersholm N; Skovgaard LT; Nielsen L; Kok-Jensen A
Acta Radiol; 2004 Jul; 45(4):424-30. PubMed ID: 15323395
[TBL] [Abstract][Full Text] [Related]
26. Maximal mid-expiratory flow detects early lung disease in α
Stockley JA; Ismail AM; Hughes SM; Edgar R; Stockley RA; Sapey E
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28356373
[TBL] [Abstract][Full Text] [Related]
27. Progression parameters for emphysema: a clinical investigation.
Stolk J; Putter H; Bakker EM; Shaker SB; Parr DG; Piitulainen E; Russi EW; Grebski E; Dirksen A; Stockley RA; Reiber JH; Stoel BC
Respir Med; 2007 Sep; 101(9):1924-30. PubMed ID: 17644366
[TBL] [Abstract][Full Text] [Related]
28. Lung density associates with survival in alpha 1 antitrypsin deficient patients.
Green CE; Parr DG; Edgar RG; Stockley RA; Turner AM
Respir Med; 2016 Mar; 112():81-7. PubMed ID: 26874894
[TBL] [Abstract][Full Text] [Related]
29. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
[TBL] [Abstract][Full Text] [Related]
31. The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency: The Association Between Diagnostic Delay and Worsened Clinical Status.
Tejwani V; Nowacki AS; Fye E; Sanders C; Stoller JK
Respir Care; 2019 Aug; 64(8):915-922. PubMed ID: 30914495
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and radiological outcomes of lung nodules in alpha 1-antitrypsin deficiency.
Subramanian DR; Edgar R; Ward H; Parr DG; Stockley RA
Respir Med; 2013 Jun; 107(6):863-9. PubMed ID: 23337299
[TBL] [Abstract][Full Text] [Related]
33. Volume adjustment of lung density by computed tomography scans in patients with emphysema.
Shaker SB; Dirksen A; Laursen LC; Skovgaard LT; Holstein-Rathlou NH
Acta Radiol; 2004 Jul; 45(4):417-23. PubMed ID: 15323394
[TBL] [Abstract][Full Text] [Related]
34. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease.
Nambu A; Zach J; Schroeder J; Jin G; Kim SS; Kim YI; Schnell C; Bowler R; Lynch DA
Eur J Radiol; 2016 Nov; 85(11):2144-2151. PubMed ID: 27776670
[TBL] [Abstract][Full Text] [Related]
35. The relationship of chronic sputum expectoration to physiologic, radiologic, and health status characteristics in alpha(1)-antitrypsin deficiency (PiZ).
Dowson LJ; Guest PJ; Stockley RA
Chest; 2002 Oct; 122(4):1247-55. PubMed ID: 12377849
[TBL] [Abstract][Full Text] [Related]
36. Relations between cardiopulmonary exercise testing and quantitative high-resolution computed tomography associated in patients with alpha-1-antitrypsin deficiency.
Schwaiblmair M; Beinert T; Seemann M; Behr J; Reiser M; Vogelmeier C
Eur J Med Res; 1998 Nov; 3(11):527-32. PubMed ID: 9810033
[TBL] [Abstract][Full Text] [Related]
37. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
[TBL] [Abstract][Full Text] [Related]
38. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.
Parr DG; Dirksen A; Piitulainen E; Deng C; Wencker M; Stockley RA
Respir Res; 2009 Aug; 10(1):75. PubMed ID: 19678952
[TBL] [Abstract][Full Text] [Related]
39. Alpha1-antitrypsin deficiency. 7: Computed tomographic imaging in alpha1-antitrypsin deficiency.
Shaker SB; Stavngaard T; Stolk J; Stoel B; Dirksen A
Thorax; 2004 Nov; 59(11):986-91. PubMed ID: 15516477
[TBL] [Abstract][Full Text] [Related]
40. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.
Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
Int J Chron Obstruct Pulmon Dis; 2017; 12():1427-1437. PubMed ID: 28553095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
